Glycemic control improved similarly with both basal insulins ; least squares mean ( SD ) reduction from baseline was -0.57 % ( 0.09 ) for Gla-300 and -0.56 % ( 0.09 ) for Gla-100 ( mean difference -0.01 % [ 95 % CI -0.14 to 0.12 ] ) , with 10 % higher dose of Gla-300 .